CARFILZOMIB for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where CARFILZOMIB was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for CARFILZOMIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 2,238 | 10.3% | 748 | 426 |
| Off label use | 2,120 | 9.7% | 361 | 393 |
| Death | 1,442 | 6.6% | 1,441 | 249 |
| Thrombocytopenia | 1,265 | 5.8% | 284 | 385 |
| Fatigue | 1,048 | 4.8% | 131 | 205 |
| Pneumonia | 1,016 | 4.7% | 334 | 634 |
| Pyrexia | 969 | 4.4% | 170 | 590 |
| Anaemia | 910 | 4.2% | 212 | 373 |
| Dyspnoea | 881 | 4.0% | 141 | 338 |
| Neutropenia | 874 | 4.0% | 190 | 213 |
| Diarrhoea | 764 | 3.5% | 157 | 285 |
| Acute kidney injury | 746 | 3.4% | 201 | 493 |
| Nausea | 707 | 3.2% | 113 | 194 |
| Disease progression | 622 | 2.9% | 166 | 144 |
| Hypertension | 609 | 2.8% | 127 | 228 |
Other Indications for CARFILZOMIB
Plasma cell myeloma (15,333)
Product used for unknown indication (4,210)
Plasma cell myeloma refractory (1,208)
Plasma cell leukaemia (186)
Off label use (143)
Acute lymphocytic leukaemia (86)
Plasma cell myeloma recurrent (66)
Plasmacytoma (66)
Chemotherapy (51)
Amyloidosis (44)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)